Apyx Medical (APYX) Cash from Investing Activities (2011 - 2026)
Apyx Medical's (APYX) quarterly Cash from Investing Activities came in at -$66000.0 in Q2 2026, up 75.09% on a YoY basis from -$37694.0 in Q2 2025, and down 10.0% quarter-over-quarter from -$60000.0 in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Cash from Investing Activities for 16 consecutive years, with -$66000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities rose 75.09% year-over-year to -$66000.0; the trailing twelve-month figure through Jun 2026 stood at -$920000.0 (down 28.13% YoY), and the FY2025 full-year result was -$1.1 million, down 54.29% from the prior year.
- Cash from Investing Activities declined to -$66000.0 in Q2 2026 per APYX's latest filing, from -$60000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $7.1 million in Q2 2023 and bottomed at -$519000.0 in Q3 2025.
- Historically, Cash from Investing Activities has averaged $209000.0 across 5 years, with a median of -$163500.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Cash from Investing Activities tumbled 1282.76% in 2022, then surged 1873.32% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$142000.0 in 2022, then jumped by 34.51% to -$93000.0 in 2023, then tumbled by 163.44% to -$245000.0 in 2024, then retreated by 12.24% to -$275000.0 in 2025, then surged by 76.0% to -$66000.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$66000.0, -$60000.0, and -$275000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Apyx Medical | 130.67 Mn | 103.06 Mn | 8.87 Mn | -66,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -66,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | -275,000.00 |
| Sep 30, 2025 | -519,000.00 |
| Jun 30, 2025 | -265,000.00 |
| Mar 31, 2025 | -55,000.00 |
| Dec 31, 2024 | -245,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Jun 30, 2024 | -289,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | -93,000.00 |
| Sep 30, 2023 | -174,000.00 |
| Jun 30, 2023 | 7.11 Mn |
| Mar 31, 2023 | -110,000.00 |
| Dec 31, 2022 | -142,000.00 |
| Sep 30, 2022 | -188,000.00 |
| Jun 30, 2022 | -401,000.00 |
| Mar 31, 2022 | -279,000.00 |
| Dec 31, 2021 | -332,000.00 |
| Sep 30, 2021 | -170,000.00 |